Clinical Trial Update: Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for a controlled release pregabalin formulation in fibromyalgia patients has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• pregabalin (controlled release formulation) (pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2018-09-14